ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.
Also called NCT03295734
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 223 participants
- Registry
-
NCT03295734
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03295734. Randomized; quadruple masking; primary purpose prevention. Start 2018-05-29 (actual); primary completion 2024-09-19 (actual). Results posted on 2025-07-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
- Acronym
- ACES
- Condition
- Hypertension
- Condition
- Aging
- Condition
- Sedentary Lifestyle
- Intervention (Behavioral)
- Aerobic exercise
- Intervention (Drug)
- Perindopril
- Intervention (Drug)
- Losartan
- Intervention (Drug)
- HCTZ
- Lead sponsor
- University of Alabama at Birmingham
- Collaborator
- University of Colorado, Denver
- Collaborator
- AdventHealth Translational Research Institute
Record details
- Record id
cardio:ct-nct03295734- Content hash
213e8047b6d30eccc60f3840bee867402cca9788dd27fee38f700263bd4c2b8e